CN Stock MarketDetailed Quotes
000650 Renhe Pharmacy
- 6.03
- -0.13-2.11%
Market Closed Dec 13 15:00 CST
8.44BMarket Cap19.08P/E (TTM)
6.15High6.02Low402.50KlotVolume6.15Open6.16Pre Close244.58MTurnover3.02%Turnover Ratio14.89P/E (Static)1.40BShares7.2252wk High1.38P/B8.03BFloat Cap4.8952wk Low6.78Limit Up1.33BShs Float16.18Historical High5.54Limit Down2.11%Amplitude-1.12Historical Low0.20Dividend TTM6.08Avg Price259.27KlotAsk3.32%Div YieldTTM100Lot Size136.02KlotBid
Renhe Pharmacy Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -17.49%3.15B | -11.84%2.36B | -8.72%1.24B | -2.35%5.03B | -0.70%3.82B | 4.72%2.68B | 3.39%1.36B | 4.41%5.15B | 5.09%3.85B | 6.60%2.56B |
| Operating revenue | -17.49%3.15B | -11.84%2.36B | -8.72%1.24B | -2.35%5.03B | -0.70%3.82B | 4.72%2.68B | 3.39%1.36B | 4.41%5.15B | 5.09%3.85B | 6.60%2.56B |
| Other operating revenue | ---- | 45.95%13.18M | ---- | 33.87%105.17M | ---- | 62.02%9.03M | ---- | -16.82%78.56M | ---- | -43.54%5.57M |
| Total operating cost | -15.39%2.59B | -11.90%1.92B | -1.56%1.06B | -3.88%4.05B | -2.56%3.06B | 3.19%2.17B | 0.08%1.07B | 6.48%4.21B | 8.65%3.15B | 9.62%2.11B |
| Operating cost | -17.05%1.96B | -12.50%1.46B | -4.58%783.9M | -3.13%3.16B | -3.54%2.37B | 2.87%1.67B | 0.20%821.52M | 6.69%3.27B | 9.06%2.46B | 10.73%1.62B |
| Operating tax surcharges | -8.41%33.19M | -7.34%23.16M | -14.20%11.62M | 10.75%49.18M | 10.78%36.23M | 21.22%24.99M | 19.21%13.54M | 14.24%44.41M | 12.96%32.71M | 5.14%20.62M |
| Operating expense | -13.56%359.77M | -12.71%269.19M | 19.23%174.27M | -3.25%540.43M | -1.45%416.2M | 5.14%308.4M | -7.14%146.16M | -6.31%558.58M | -5.18%422.33M | -8.03%293.32M |
| Administration expense | -4.53%222.31M | -4.95%157.18M | -4.60%87.56M | -13.35%269.92M | 8.15%232.85M | 3.68%165.36M | 22.77%91.78M | 20.46%311.5M | 24.47%215.31M | 27.62%159.49M |
| Financial expense | 45.75%-9.82M | 26.21%-8.75M | 2.01%-6.77M | -8.06%-24.92M | 8.52%-18.09M | 17.47%-11.86M | -49.13%-6.91M | 58.25%-23.06M | 57.45%-19.78M | 55.25%-14.37M |
| -Interest expense (Financial expense) | -66.10%95.57K | -60.85%79.54K | -56.36%47.64K | -19.29%345.1K | -15.55%281.87K | -5.22%203.18K | -7.91%109.18K | -56.30%427.6K | -47.34%333.76K | -68.11%214.38K |
| -Interest Income (Financial expense) | 44.80%-11.68M | 22.69%-11.1M | -14.21%-8.08M | -18.51%-28.66M | -4.83%-21.16M | 2.39%-14.35M | -52.74%-7.08M | 57.36%-24.18M | 57.24%-20.18M | 55.32%-14.71M |
| Research and development | -21.12%23.2M | -19.80%17.53M | -15.82%6.47M | -8.26%46.36M | -25.61%29.41M | -24.58%21.86M | -45.47%7.68M | -3.08%50.54M | -7.54%39.54M | 1.11%28.98M |
| Credit Impairment Loss | -176.05%-4.56M | -170.64%-4.46M | -49.80%39.79K | 41.22%-3.92M | 36.32%-1.65M | 38.27%-1.65M | 45,189.22%79.26K | -175.79%-6.67M | -5,342.98%-2.6M | -622.84%-2.67M |
| Asset Impairment Loss | ---185.02K | ---398.79K | --0 | -224.58%-223.11M | --0 | ---- | --91.69K | -1,256.96%-68.74M | -98.03%4.42K | -94.57%4.57K |
| Other net revenue | 21.74%128.42M | 75.50%96.04M | 500.60%84.26M | -1,167.59%-88.45M | 105.61%105.49M | 42.37%54.72M | -26.66%14.03M | -84.42%8.28M | 109.73%51.3M | 93.86%38.44M |
| Fair value change income | -166.35%-720.97K | -155.63%-953.37K | -229.79%-849.83K | -23.90%16.83M | 94.43%-270.68K | 156.44%1.71M | 116.53%654.76K | 85,137.67%22.11M | -47.39%-4.86M | -417.47%-3.04M |
| Invest income | -60.08%21.52M | -30.79%9.34M | -16.70%6.93M | 27.96%59.26M | 86.37%53.92M | -40.26%13.5M | 70.96%8.32M | 47.14%46.31M | 58.66%28.93M | 68.07%22.6M |
| -Including: Investment income associates | ---3.28M | ---1.98M | ---- | -150.75%-914.95K | --0 | --0 | ---- | 29,883.71%1.8M | ---- | ---- |
| Asset deal income | -735.49%-187.41K | -1,925.41%-201.62K | ---201.62K | -180.13%-270.2K | 427.94%29.49K | 261.78%11.05K | --0 | -98.00%337.21K | 100.70%5.59K | 7,547.95%3.05K |
| Other revenue | 110.51%112.55M | 125.32%92.71M | 1,505.70%78.34M | 320.30%62.77M | 79.31%53.47M | 91.04%41.14M | -73.22%4.88M | 20.62%14.93M | 193.81%29.82M | 196.88%21.54M |
| Operating profit | -20.18%685.9M | -3.13%544.63M | -10.54%264.86M | -5.73%898.63M | 14.30%859.3M | 14.20%562.21M | 14.91%296.05M | -8.07%953.26M | -4.73%751.78M | -1.54%492.3M |
| Add:Non operating Income | 28.46%2.75M | 31.48%1.71M | -2.46%779.78K | -23.66%4.23M | -22.88%2.14M | 21.91%1.3M | 59.49%799.45K | 85.95%5.54M | -87.75%2.78M | 227.79%1.07M |
| Less:Non operating expense | 95.47%5.29M | 94.98%4.63M | -27.43%1.24M | -23.93%4M | -32.27%2.7M | -30.70%2.38M | 84.14%1.71M | -4.14%5.26M | -35.10%3.99M | 125.47%3.43M |
| Total profit | -20.42%683.37M | -3.46%541.7M | -10.42%264.4M | -5.73%898.86M | 14.41%858.73M | 14.53%561.14M | 14.75%295.14M | -7.82%953.54M | -6.83%750.56M | -1.78%489.93M |
| Less:Income tax cost | -18.28%168.46M | -2.92%129M | -28.01%54.6M | 11.34%269.45M | 12.35%206.14M | 12.05%132.88M | 20.50%75.85M | 3.18%242M | 2.84%183.48M | 11.78%118.59M |
| Net profit | -21.10%514.9M | -3.63%412.71M | -4.33%209.8M | -11.54%629.41M | 15.08%652.59M | 15.33%428.26M | 12.88%219.29M | -11.04%711.54M | -9.58%567.08M | -5.44%371.35M |
| Net profit from continuing operation | -21.10%514.9M | -3.63%412.71M | -4.33%209.8M | -11.54%629.41M | 15.08%652.59M | 15.33%428.26M | 12.88%219.29M | -11.04%711.54M | -9.58%567.08M | -5.44%371.35M |
| Less:Minority Profit | -11.58%99.23M | 5.32%75.53M | -12.15%32.5M | -54.67%62.15M | 1.44%112.22M | 0.46%71.71M | -4.08%36.99M | 1.68%137.11M | 7.95%110.62M | 17.64%71.38M |
| Net profit of parent company owners | -23.08%415.68M | -5.43%337.18M | -2.74%177.3M | -1.25%567.26M | 18.38%540.38M | 18.86%356.55M | 17.09%182.3M | -13.62%574.43M | -13.01%456.46M | -9.66%299.97M |
| Earning per share | ||||||||||
| Basic earning per share | -23.08%0.2969 | -5.42%0.2409 | -2.76%0.1266 | 0.00%0.41 | 18.37%0.386 | 18.85%0.2547 | 17.09%0.1302 | -14.58%0.41 | -12.99%0.3261 | -9.65%0.2143 |
| Diluted earning per share | -23.08%0.2969 | -5.42%0.2409 | -2.76%0.1266 | 0.00%0.41 | 18.37%0.386 | 18.85%0.2547 | 17.09%0.1302 | -14.58%0.41 | -12.99%0.3261 | -9.65%0.2143 |
| Other composite income | ||||||||||
| Total composite income | -21.10%514.9M | -3.63%412.71M | -4.33%209.8M | -11.54%629.41M | 15.08%652.59M | 15.33%428.26M | 12.88%219.29M | -11.04%711.54M | -9.58%567.08M | -5.44%371.35M |
| Total composite income of parent company owners | -23.08%415.68M | -5.43%337.18M | -2.74%177.3M | -1.25%567.26M | 18.38%540.38M | 18.86%356.55M | 17.09%182.3M | -13.62%574.43M | -13.01%456.46M | -9.66%299.97M |
| Total composite income of minority owners | -11.58%99.23M | 5.32%75.53M | -12.15%32.5M | -54.67%62.15M | 1.44%112.22M | 0.46%71.71M | -4.08%36.99M | 1.68%137.11M | 7.95%110.62M | 17.64%71.38M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
